About the journal
Hematological Oncology is a journal published by Wiley in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,220 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 0278-0232 · 1099-1069
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,220 USD
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/10991069
Index listings
- MEDLINE · 1983-01-01
- PUBMED · 2016-07-29
- Indexing
- MEDLINE · PUBMED
- APC
- 4,220 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 116 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
6013
Last recorded publication year
2026
h-index
73
i10-index
1143
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 24%
- ORCID iDs in current deposits
- 22%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 8307268
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- CAR-T cell therapy research
- CAR-T cell therapy research
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
Show all subjects (50)
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- T-cell and Retrovirus Studies
- T-cell and Retrovirus Studies
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Immunodeficiency and Autoimmune Disorders
- Hematopoietic Stem Cell Transplantation
- Immunodeficiency and Autoimmune Disorders
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Educational Robotics and Engineering
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Educational Robotics and Engineering
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ